Toxic shock syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(13 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
 
{{Toxic shock syndrome}}
{{CMG}},{{AE}}{{MIR}}
{{CMG}},{{AE}}{{MIR}}
==Overview''':'''==
==Overview''':'''==
[[Laboratory findings template|Laboratory finding]]<nowiki/>s consistent with the diagnosis of [[toxic shock syndrome]] (TSS) include [[leukocytosis]], [[anemia]] and [[thrombocytopenia]].
[[Laboratory findings template|Laboratory finding]]<nowiki/>s consistent with the diagnosis of [[toxic shock syndrome]] (TSS) include [[leukocytosis]], [[anemia]] and [[thrombocytopenia]]. A positive [[blood culture]] is diagnostic for [[Streptococcus|Streptococcal]] TSS, although in other causes of TSS [[blood culture]] doesn't have a high value.
 
A positive [[blood culture]] is diagnostic for [[Streptococcus|Streptococcal]] TSS, although in other causes of TSS [[blood culture]] doesn't have a high value.


==Laboratory Findings==
==Laboratory Findings==
Line 12: Line 10:
=== Primary General Electrolyte and Biomarker Studies<ref name="pmid8418347">{{cite journal |vauthors= |title=Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections |journal=JAMA |volume=269 |issue=3 |pages=390–1 |year=1993 |pmid=8418347 |doi= |url=}}</ref><ref name="pmid3890787">{{cite journal |vauthors=Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR |title=Streptococcal myositis |journal=Arch. Intern. Med. |volume=145 |issue=6 |pages=1020–3 |year=1985 |pmid=3890787 |doi= |url=}}</ref> ===
=== Primary General Electrolyte and Biomarker Studies<ref name="pmid8418347">{{cite journal |vauthors= |title=Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections |journal=JAMA |volume=269 |issue=3 |pages=390–1 |year=1993 |pmid=8418347 |doi= |url=}}</ref><ref name="pmid3890787">{{cite journal |vauthors=Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR |title=Streptococcal myositis |journal=Arch. Intern. Med. |volume=145 |issue=6 |pages=1020–3 |year=1985 |pmid=3890787 |doi= |url=}}</ref> ===
{| class="wikitable"
{| class="wikitable"
!Laboratory Exam
! align="center" style="background:#4479BA; color: #FFFFFF;" |Laboratory Tests
!Result
! align="center" style="background:#4479BA; color: #FFFFFF;" |Result
|-
|-
| rowspan="4" |[[Complete blood count]] (CBC)
| rowspan="4" align="center" style="background:#DCDCDC;"|[[Complete blood count]] (CBC)
|[[Leukocytosis]] with a left shift
|[[Leukocytosis]] with a left shift
|-
|-
Line 24: Line 22:
|[[Anemia]]
|[[Anemia]]
|-
|-
|Blood culture
|align="center" style="background:#DCDCDC;"|Blood culture
|[[Bacteremia]]
|[[Bacteremia]]
|-
|-
| rowspan="2" |[[Renal function tests]]
| rowspan="2" align="center" style="background:#DCDCDC;"|[[Renal function tests]]
|Elevated serum [[BUN]] and [[creatinine]]
|Elevated serum [[BUN]] and [[creatinine]]
|-
|-
|[[Urine appearance|Urine Analysis]]: [[Hemoglobinuria]]
|[[Urine appearance|Urine Analysis]]: [[Hemoglobinuria]]
|-
|-
| rowspan="2" |[[Liver function tests|Liver Function Tests]]
| rowspan="2" align="center" style="background:#DCDCDC;"|[[Liver function tests|Liver Function Tests]]
|Elevated [[Transaminase|transaminases]] and [[bilirubin]]
|Elevated [[Transaminase|transaminases]] and [[bilirubin]]
|-
|-
|[[hypoalbuminemia]]
|[[Hypoalbuminemia]]
|-
|-
|Serum [[lactic acid]]
|align="center" style="background:#DCDCDC;"|Serum [[lactic acid]]
|Elevated
|[[Lactic acidosis|Hyper lactic acidosis]]
|-
|-
| rowspan="3" |Metabolic tests
| rowspan="3" align="center" style="background:#DCDCDC;"|Metabolic tests
|[[hypocalcemia]]
|[[Hypocalcemia]]
|-
|-
|[[hyponatremia]]
|[[Hyponatremia]]
|-
|-
|[[hypophosphatemia]]
|[[Hypophosphatemia]]
|-
|-
| rowspan="2" |Blood gas analysis:
| rowspan="2"v align="center" style="background:#DCDCDC;"|Blood gas analysis:
Venous blood gas (VBG) and arterial blood gas analysis (ABG)
Venous blood gas (VBG) and arterial blood gas analysis (ABG)
|[[Hypoxemia]] may be present as a result of [[pulmonary edema]] and [[pleural effusion]]
|[[Hypoxemia]] may be present as a result of [[pulmonary edema]] and [[pleural effusion]]
[[Metabolic acidosis]]
|-
|-
|[[Metabolic acidosis]] and elevated [[pH]]
| align="center" style="background:#DCDCDC;"|[[Creatine phosphokinase|Creatine phosphokinase (CPK)]]
|-
|[[Creatine phosphokinase|Creatine phosphokinase (CPK)]]
|Elevated
|Elevated
|}
|}
Line 60: Line 57:
{| class="wikitable"
{| class="wikitable"
|-
|-
!Exam
! align="center" style="background:#4479BA; color: #FFFFFF;" |Laboratory Tests
!Result
! align="center" style="background:#4479BA; color: #FFFFFF;" |Result
|-
|-
|Blood microscopy and culture (blood, wound, fluid, tissue)
|align="center" style="background:#DCDCDC;"|Blood microscopy and culture (blood, wound, fluid, tissue)
|Positive for group A [[streptococcus]] or [[Staphylococcus aureus]]
|Positive for group A [[streptococcus]] or [[Staphylococcus aureus]]
|-
|-
|[[Prothrombin time]]
| align="center" style="background:#DCDCDC;"|[[Prothrombin time]]
|Prolonged in [[Staphylococcus|staphylococcal]] disease in conjunction with [[DIC]]
|Prolonged in [[Staphylococcus|staphylococcal]] disease in conjunction with [[DIC]]
|-
|-
|[[Partial thromboplastin time]]
| align="center" style="background:#DCDCDC;"|[[Partial thromboplastin time]]
|Prolonged in [[staphylococcal]] disease in conjunction with [[DIC]]
|Prolonged in [[staphylococcal]] disease in conjunction with [[DIC]]
|-
|-
|[[Creatine kinase|Creatine kinase (CK)]]
| align="center" style="background:#DCDCDC;"|[[Creatine kinase|Creatine kinase (CK)]]
|Elevated in [[necrotizing fasciitis]] or [[myositis]] and in some [[Staphylococcus|staphylococcal]] disease
|Elevated in [[necrotizing fasciitis]] or [[myositis]] and in some [[Staphylococcus|staphylococcal]] disease
|-
|-
|[[Polymerase chain reaction|Polymerase chain reaction (PCR)]]
| align="center" style="background:#DCDCDC;"|[[Polymerase chain reaction|Polymerase chain reaction (PCR)]]
|Protracted expansion of TSST-1–reactive Vβ2-positive T cells persisting for 4–5 weeks
|Protracted expansion of TSST-1–reactive Vβ2-positive T cells persisting for 4–5 weeks
|-
|-
|Serotyping
| align="center" style="background:#DCDCDC;"|Serotyping
|Evidence of [[Streptococcus|streptococcal]] [[Exotoxin|exotoxins]]
|Evidence of [[Streptococcus|streptococcal]] [[Exotoxin|exotoxins]]
|}
|}
Line 90: Line 87:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Syndromes]]
[[Category:Syndromes]]
[[Category:Infectious disease]]
[[Category:Needs overview]]
[[Category:Needs overview]]
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 00:27, 30 July 2020

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome laboratory findings

CDC on Toxic shock syndrome laboratory findings

Toxic shock syndrome laboratory findings in the news

Blogs on Toxic shock syndrome laboratory findings

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview:

Laboratory findings consistent with the diagnosis of toxic shock syndrome (TSS) include leukocytosis, anemia and thrombocytopenia. A positive blood culture is diagnostic for Streptococcal TSS, although in other causes of TSS blood culture doesn't have a high value.

Laboratory Findings

The International Guideline Committee for diagnosis of septic shock recommends obtaining appropriate cultures that may include at least two blood cultures, urine, cerebrospinal fluid, wounds, respiratory secretions, or other body fluid cultures before antimicrobial therapy is initiated. In TSS patients, blood culture for staphylococcus is not diagnostic, although blood culture for streptococcal TSS is highly diagnostic.

Primary General Electrolyte and Biomarker Studies[1][2]

Laboratory Tests Result
Complete blood count (CBC) Leukocytosis with a left shift
Hematocrit levels up to 80 percent have been reported
Thrombocytopenia with platelets <100 x 10^3/microliter
Anemia
Blood culture Bacteremia
Renal function tests Elevated serum BUN and creatinine
Urine Analysis: Hemoglobinuria
Liver Function Tests Elevated transaminases and bilirubin
Hypoalbuminemia
Serum lactic acid Hyper lactic acidosis
Metabolic tests Hypocalcemia
Hyponatremia
Hypophosphatemia
Blood gas analysis:

Venous blood gas (VBG) and arterial blood gas analysis (ABG)

Hypoxemia may be present as a result of pulmonary edema and pleural effusion

Metabolic acidosis

Creatine phosphokinase (CPK) Elevated

Specialized Laboratory Tests[3]

Laboratory Tests Result
Blood microscopy and culture (blood, wound, fluid, tissue) Positive for group A streptococcus or Staphylococcus aureus
Prothrombin time Prolonged in staphylococcal disease in conjunction with DIC
Partial thromboplastin time Prolonged in staphylococcal disease in conjunction with DIC
Creatine kinase (CK) Elevated in necrotizing fasciitis or myositis and in some staphylococcal disease
Polymerase chain reaction (PCR) Protracted expansion of TSST-1–reactive Vβ2-positive T cells persisting for 4–5 weeks
Serotyping Evidence of streptococcal exotoxins

References

  1. "Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections". JAMA. 269 (3): 390–1. 1993. PMID 8418347.
  2. Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR (1985). "Streptococcal myositis". Arch. Intern. Med. 145 (6): 1020–3. PMID 3890787.
  3. Davis JP, Osterholm MT, Helms CM, Vergeront JM, Wintermeyer LA, Forfang JC, Judy LA, Rondeau J, Schell WL (1982). "Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings". J. Infect. Dis. 145 (4): 441–8. PMID 7069224.


Template:WikiDoc Sources